Introduction
Alkyl chloroformates have been used as derivatizing reagents for gas chromatographic (GC) determinations of amines, amino acids, amino alcohol and acids. [1] [2] [3] [4] [5] Husek has reviewed chloroformates in GC as a general-purpose derivatizing reagent. 6 Husek and Simek have reviewed alkyl chloroformates in sample derivatization strategies for GC analysis on a decade use as an esterifying reagent. 7 Isoniazid (INH) (isonicotinoylhydrazine) is the most potent and selective tuberculostatic antibacterial agent in the therapy of tuberculosis. 8 It inhibits the in vitro growth of tubercle bacillus below 1 mg/ml. 9 It is also used as a propylactic for persons constantly exposed to tubercular patients. The INH gains access to all organs and all the body fluids, including cerebrospinal fluids, which render the drugs special value in treating tuberculosis meningitis and other extra pulmonary forms of the disease. Even if used alone, it is equal in efficiency to streptomycin. It is believed to affect lipids, nucleic acids and glycolysis or mycolic acid biosynthesis. 10 Hydrazine (HZ) is a toxic substance and may be present in INH-based pharmaceuticals preparations as one of the decomposition products. 11 Various analytical techniques, such as titrimetry, 12, 13 spectrophotometry, [14] [15] [16] spectrofluorometry, 17 atomic absorption, 18 chemiluminescence, 19 electroanalytical techniques, 20,21 kinetic determination, 22 flow injection, 23, 24 thin layer chromatography, 25, 26 capillary electrophoresis 27, 28 and liquid chromatography [29] [30] [31] [32] have been used for the quantitation of INH in pharmaceutical preparations and biological samples. Liquid chromatography with UV detection is carried out either by measuring the perse absorbance of INH at 263 nm or by precolumn derivatization with a suitable derivatizing reagent. [33] [34] [35] [36] [37] The determination limit for INH has been reported within 0.5 -8.0 mg/ml. 25 Capillary gas chromatography shows better separated narrow peaks. The GC of INH was carried out after derivatization with trifluoroacetic anhydride, bis(trimethylsilyl)trifluoroacetamide or trifluoroacetylacetone and was quantified by flame ionization detection (FID) or mass spectrometry. [38] [39] [40] Quantitation was carried out within the limits of 2.5 -25.0 mg/ml. 40 The use of a simple and inexpensive derivatizing reagent for the GC determination of INH and HZ from a pharmaceutical preparation could be of analytical interest for quality control. The present work examined the capillary GC determination of INH and HZ using PHZ as an internal standard after derivatization with ethyl chloroformate (ECF) with FID. The reagent ECF may prove to be an additional GC reagent for the selective determination of INH and HZ.
Experimental

Materials and reagents
All of the chemicals used were of reagent or pharmaceutical grade. Freshly prepared double-distilled water was used throughout the study. Pure INH was obtained from Nabi Qasim Pharmaceuticals, Karachi, Pakistan. HZ (24%), PHZ, ECF, and ethanol were purchased from E. Merck, Darmstadt, Germany. The percentage of HZ in solution was determined by titrimetry. Buffer solutions in the pH range 1 -12 at unit interval were prepared from hydrochloric acid (0.1 M) and potassium chloride (1 M) (pH 1 and 2); acetic acid (1 M) and sodium acetate (1 M) (pH 3 to 6); ammonium acetate (pH 7); sodium bicarbonate (1 M) and sodium carbonate saturated (pH 8 and 9); ammonium chlorides (1 M) and ammonia (1 M) (pH 10 and 11); sodium hydroxide (pH 12). The INH solution used was prepared by dissolving 10.95 mg of INH in ethanol-water (1:1, v/v), and the final volume was adjusted to 10 ml. GC studies were carried out on an Agilent Model 6890 Net work GC system (Agilent Technologies Inc., USA) coupled with a split/splitless injector,
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Ethyl chloroformate was examined as a precolumn derivatizing reagent for the gas chromatographic (GC) determination of isoniazid (INH) and hydrazine (HZ). Phenylhydrazine (PHZ) was used as an internal standard. was used throughout the study. An Orion Model 420A pH meter (Orion Research Inc., Boston, USA) with a glass electrode with a combined reference electrode was used for pH measurements.
Gas chromatographic determination
To a solution (1 -5 ml) containing INH (1.5 -15 mg), HZ (1.4 -14.0 mg) and PHZ (23.2 mg) was added a 0.4-ml pyridine solution, followed by 0.5 ml of pure ECF and 1 ml of 1 Mcarbonate solution, pH 9. The contents were sonicated for 15 min, and chloroform (0.5 ml) was added. The mixture was mixed well and layers were allowed to separate. Then, 0.50 ml of extract layer (1 ml) was pipetted out to a screw-capped vial. The solvent was evaporated and redissolved in 0.2 ml of ethanol. The solution (1 ml) was used and eluted from a capillary GC column HP-5 at a column temperature of 150˚C for 1 min with a programmed heating rate of 10˚C/min up to 250˚C with a total run time 11 min. The nitrogen flow rate was maintained at 4 ml/min. The injection port and detector temperatures were fixed at 250 and 300˚C, respectively. The hydrogen and nitrogen flow rates were fixed at 40 and 45 ml/min, respectively for FID detection. The split ratio was 10:1, v/v.
Determination of isoniazid in pharmaceutical preparations
Ten tablets of each of Remactal, Remactal (450) (Novartis Pharma, Pak Ltd., Karachi) and Weyeth Myambutaol (Wyeth Pak, Ltd., Karachi) were powdered, and 60.0 mg Remactal, 90 mg Weyeth Myambutaol and 90 mg of Remactal (450) were dissolved in each portion (6 ml) of ethanol-water (1:1, v/v). The solution was filtered and the final volume was adjusted to 50 ml with ethanol-water (1:1, v/v). The solution (1 ml) was transferred to a screw-capped vial and 1 ml of chloroform was added. The contents were mixed well and the layers were allowed to separate. The aqueous layer was collected, to which was added PHZ (23.2 mg) followed by the above "GC determination". Ten tablets of INH (Unexo Lab. Ltd., Lahore) were thoroughly ground, and the powder (80 mg) was dissolved in ethanol-water (1:1, v/v); the resulting solution was filtered. The final volume was adjusted to 100 ml. To the solution (1 ml) was added PHZ (23.2 mg), and the procedure above followed. Well-mixed INH syrup (1 ml) was dissolved in ethanol-water (1:1, v/v) and filtered. The volume was adjusted to 100 ml. The solution 1 ml was further diluted to 100 ml. To the solution (1 ml) was added PHZ (23.2 mg) and processed according to the procedure above. The amounts of INH in pharmaceutical preparations were evaluated from the ratio of the peaks of the analyte to the internal standard and external calibration curve.
Determination of isoniazid from INH syrup by standard addition method
Isoniazid syrup was processed according to the procedure, and two portions of the solution (1.0 ml each) were taken. A portion was processed and to the other portion was added 12.5 mg INH. Quantitation was carried out from a linear calibration, and an increase in the response for INH was used to calculate the percent recovery of INH from an INH tablet solution.
Determination of hydrazine from isoniazid formulation
Ten tablets of Remactal (450) containing 300 mg of INH tablet were thoroughly ground, and the powder (0.5 g containing 187.5 mg INH) was dissolved in ethanol-water (1:1, v/v) and the solution filtered and adjusted to 10 ml. A solution of 3 ml was taken, followed by the procedure above. Well-mixed INH syrup (2 ml) containing (10 mg/ml) INH was dissolved in ethanolwater (1:1, v/v), 5 ml, and the whole solution was processed, and the response for HZ was noted. The amount of HZ was evaluated through an external calibration curve
Results and Discussion
Optimization of reaction conditions and separation
The compounds INH, HZ and PHZ reacted with ECF to form volatile products (Fig. 1) , and eluted from a capillary GC column, each as a single peak. The reaction was carried out in methanol, acetonitrile, aqueous-methanol, aqueous-acetonitrile and an aqueous solution containing a pyridine base. A better GC response (average peak height/peak area) was observed using an aqueous solution containing pyridine as the reaction medium, and was selected. The effect of the pH on the derivatization was examined between 1 -10 at unit interval. It was observed that derivatization occurred at pH values above 6, and the maximum response was observed at pH 9 (Fig. 2) . The carbonate buffer was used since it covered the pH range satisfactorily, as has been reported for amino-containing compounds. 6 The reaction mixture was sonicated at room temperature (30˚C) for 5 -20 min at an interval of 5 min, and the optimum response was observed within 15 min. Chloroform was used for the extraction of derivatives, as reported for related compounds. 1 Ethanolic solutions of the derivatives were injected with split-mode injection on a GC column HP-5 (30 m ¥ 320 mm i.d.), and the elution and separation of INH, HZ and PHZ derivatives were examined. Each compound eluted as a symmetrical single peak separately from the derivatizing reagent. Complete separation was obtained under the optimized conditions (gas chromatographic determination). The resolution factor (Rs) between adjacent peaks was >1.5, and capacity factors k¢, for the HZ, PHZ and INH derivatives were calculated (Fig. 3) .
Quantitation and validation
Linear calibration curves obtained for INH and HZ were 3.5 -37.5 and 3.5 -35 mg/ml, and the coefficients of the determinations (r 2 ) were 0.9985 and 0.9958, respectively. The linear regression equations were y = 0.3883x + 0.4126 and y = 0.4653x + 0.4195, respectively. The limits of detection (LOD) measured with a signal-to-noise ratio of 3:1 were 1.87 and 1.75 mg/ml, corresponding to 0.18 and 0.17 ng for INH and HZ, respectively, reaching the detector. The reproducibility was checked by targeting the elution of a three-component mixture of HZ, PHZ and INH in terms of the elution time and the peak height (n = 6). The relative standard deviation (RSD) turned out to be within 0.3 -1.4 and 0.4 -2.1%, respectively. Intra-day variations (n = 4), against in terms of the elution time and the peak height, were measured and the RSD was found to be 0.5 -1.7 and 0.6 -2.3%. Test solutions of INH and HZ (n = 4) were analyzed, and the relative % error was obtained within 1 -2%.
Sample analysis
The determination of INH in pharmaceutical preparations was also examined. Analyses of INH tablets and INH syrup did not encounter any difficulty. INH was extracted from INH tablets and INH syrup with ethanol-water (1:1, v/v), and after derivatization was analyzed by GC. Tablets of Remactal, Remactal (450) and Weyeth myambutanol contained rifampicin or ethambutanol, together with INH. INH after its derivatization with ECF was extracted in chloroform, but ethambutanol remained in the aqueous phase; therefore it did not interfere with the determination of INH. The rifampicin, however, was extracted in chloroform together with the INH derivative, but did not elute from the GC column, indicating on-column decomposition, which disturbed the base line and the response of INH derivative. Thus, rifampicin was extracted in chloroform prior to the derivatization of INH with ECF. A stable response was obtained, and relative deviation from the labeled values of the manufacturer fell within 2 -6.6% with an RSD of 1 -4.2% (n = 3) ( Table 1 ). The recovery percentage of INH, calculated by the standard addition method for INH syrup, was 98% with an RSD of 2% (n = 3). The amount of HZ as the decomposition product in INH syrup and a Remactal (450) tablet was examined. HZ was found to be 1.6 mg/10 mg INH and 14.7 mg HZ/tablet with 300 mg INH with an RSD of 2.5 -3.5%. The concentration of HZ in INH syrup and the Remactal (450) tablet was below the proposed safe limit of 0.1%. For 10-fold addition of glucose, magnesium stearate, gum acacia, talcum, methylparaben, lactose and starch to INH did not affect its determination. Now, comparing the results with the reported HPLC method with UV detection, 32 which indicated a linear calibration range within 0.5 -8.0 mg/ml INH with a 50-ml loop injector with an analyses time of 15 min, as compared to the present method with linear calibration of 3.5 -37.5 mg/ml INH with 1 ml injection with a split ratio of 10:1, v/v and an analyses time of 11 min. The GC procedure is also free from the problem of safe disposal the used mobile phase. 
Conclusions
A simple GC procedure has been developed for the determination of INH and HZ from a pharmaceutical preparation after precolumn derivatization with ECF. HZ and PHZ separated completely. The detection limit observed for HZ and INH corresponded to 0.17 and 0.18 ng reaching the FID detector. The analyses of pharmaceutical preparations were observed with an RSD of 1 -4.2%.
